Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

IMT News Desk
IMT News Desk
· 2 min read
Annora Pharma expands its collaboration with AI‑native traceability platform AltiusHub to strengthen global drug traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations.

The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply chain. The rollout supports compliance across key export markets, including the US, EU, GCC, LATAM, and ASEAN regions.

Annora Pharma aims to achieve real-time visibility across 100% of serialized drug products within three months. The unified platform replaces fragmented legacy systems. It supports serialization, aggregation, and multi-market regulatory reporting. It also integrates with Annora Pharma’s Level 3 packaging infrastructure.

AltiusHub’s AI-driven analytics and automated exception management help improve operational efficiency. They also accelerate issue resolution and strengthen compliance oversight across markets.

The deployment has already resulted in faster serialization processing and improved packaging floor productivity. It has also enhanced real-time visibility across export supply chains. These capabilities are becoming critical as pharmaceutical manufacturers respond to evolving regulatory mandates and increasing supply chain complexity.

As supply chains become more complex, limited data access in legacy systems is becoming a growing challenge. While technology has advanced, many systems have not kept pace. Today, pharmaceutical companies need solutions that provide greater control over their data and processes. AltiusHub has enabled our teams to manage serialization and traceability workflows with greater transparency, flexibility, and independence.”Dr Bhaskar Reddy, Director, Hetero Group

We need systems that give our teams real-time visibility, faster issue resolution, and greater control over compliance workflows. AltiusHub has helped us simplify these operations while improving efficiency across the packaging and dispatch process.”Mr Sridhar Reddy, Operations Head, Annora Pharma

For a long time, pharma companies have had to accept that traceability implementations are slow, resource-intensive, and heavily dependent on vendors. AltiusHub’s go-live at Annora Pharma shows that this model is changing. An AI-native solution like AltiusHub delivers speed, scalability, and control while meeting the strict regulatory standards the industry requires.”Siddharth Reddy, Managing Director, AltiusHub

Within two years of inception, AltiusHub has enabled serialization and compliance operations across more than 50 regulated markets. These include the United States under DSCSA, the European Union under FMD, Saudi Arabia under SFDA, the UAE under Tatmeen, Russia under Chestny ZNAK, and other export destinations.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk